BioNexus Gene Lab Corp. (BGLC)
undefined
undefined%
At close: undefined
0.42
-12.40%
After-hours Jan 03, 2025, 05:55 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 9.77M 10.93M 13.36M 11.39M 126.95K 212.33K 107.68K n/a
Cost of Revenue 8.44M 9.67M 11.17M 9.67M 71.07K 183.56K 28.87K n/a
Gross Profit 1.33M 1.26M 2.19M 1.72M 55.89K 28.77K 78.81K n/a
Operating Income -2.59M -291.18K 1.06M 1.27M -275.70K 59.90K -127.91K -840
Interest Income n/a 12.48K 12.97K 11.31K n/a n/a n/a n/a
Pretax Income -2.61M -303.66K 1.04M 1.26M -275.70K 59.90K -119.41K -835
Net Income -2.63M -355.97K 751.57K 1.09M -246.47K 26.45K -123.75K -835
Selling & General & Admin 4.41M 1.73M 1.20M 1.33M 356.64K 241.93K 206.72K 835.00
Research & Development n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses -486.04K -179.28K -66.49K -886.94K -25.05K 273.07K n/a n/a
Operating Expenses 3.92M 1.55M 1.14M 446.00K 331.59K -31.14K 206.72K 835.00
Interest Expense 13.93K 12.48K 12.97K 11.31K n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 12.36M 11.22M 12.31M 10.12M 402.66K 152.43K 235.59K 835.00
Income Tax 21.53K 52.31K 291.28K 168.41K -29.24K 33.45K 4.34K -835
Shares Outstanding (Basic) 15.88M 14.41M 14.27M 8.58M 7.20M 5.53M 6.22M 6.22M
Shares Outstanding (Diluted) 15.88M 14.41M 14.27M 8.58M 7.20M 5.53M 6.22M 6.22M
EPS (Basic) -0.17 -0.02 0.05 0.13 -0.03 0.00 -0.02 -0.00
EPS (Diluted) -0.17 -0.02 0.05 0.13 -0.03 0.00 -0.02 -0.00
EBITDA -2.49M -185.76K 1.16M 1.38M -222.37K 100.51K -104.38K n/a
Depreciation & Amortization 108.42K 105.42K 108.22K 101.60K 53.33K 40.61K 15.03K 835.00

Create Price Alert on BGLC

Your price alert will notify you when the stock price is above 0.48.

Add to Watchlist